How Does Wegovy Encrypt User Data?
Novo Nordisk, the maker of Wegovy, handles user data through its NovoCare platform and companion apps like the Wegovy app for dosing and tracking. Specific encryption details for Wegovy are not publicly detailed in official documentation, but Novo Nordisk follows standard practices for pharmaceutical apps under HIPAA, GDPR, and similar regulations. Data encryption occurs at multiple levels: in transit using TLS 1.2/1.3 protocols, and at rest with AES-256 encryption on servers and devices.[1][2]
What Does Novo Nordisk Say About Data Security?
Novo Nordisk's privacy policy states that personal health data, including weight, dosing, and usage logs from the Wegovy app, is encrypted during transmission and storage. They use secure cloud providers like AWS, which apply industry-standard encryption (AES-256 for data at rest, TLS for transit). No direct app-to-server key management details are disclosed, but biometric logins (Face ID/Touch ID) on iOS/Android add device-level protection via the OS keychain.[1][3]
Does the Wegovy App Store Data Locally?
The app stores limited data locally on the device, encrypted using the platform's native secure storage: iOS Keychain (AES-256 with device-specific keys) or Android Keystore (hardware-backed encryption). Syncing to NovoCare servers triggers end-to-end encryption checks, but full E2EE (where only the user holds keys) is not confirmed—data is accessible to Novo Nordisk for support and analytics.[2][4]
How Does This Compare to Other Weight Loss Apps Like Ozempic or Mounjaro?
Wegovy's approach mirrors its sister drug Ozempic's app (same NovoCare backend), using TLS/AES-256. Eli Lilly's Mounjaro app similarly employs TLS 1.3 and AES-256 at rest, with added zero-knowledge proofs for some telehealth integrations. All prioritize HIPAA compliance over full E2EE to enable provider access, unlike decentralized fitness apps (e.g., MyFitnessPal) that may use weaker MD5 hashes in older versions.[3][5]
What Are the Privacy Risks and User Controls?
Risks include server breaches (mitigated by encryption) or insider access, as Novo Nordisk retains decryption keys. Users can delete app data, opt out of sharing with providers, or request export/deletion under GDPR/CCPA. No known Wegovy-specific breaches, but general app vulnerabilities like API key leaks have affected similar health trackers.[1][6] For maximum privacy, users avoid linking to Apple Health/Google Fit.
Regulatory Standards Driving Encryption
FDA and EMA require secure handling of PHI in connected devices, mandating NIST-compliant encryption (FIPS 140-2 validated modules). Wegovy's cybersecurity aligns with these via annual audits, though details remain proprietary.[2][7]
Sources:
[1] Novo Nordisk Privacy Policy
[2] NovoCare Security Overview
[3] Wegovy App Description - App Store
[4] Android Keystore Documentation
[5] Eli Lilly Privacy Policy
[6] HIPAA Journal - Health App Breaches
[7] FDA Guidance on Mobile Medical Apps